A Phase III randomized study of interleukin‐2 lymphokine‐activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma

CANCER, Volume 80, Number 1, 42-49.(1997)

 

登入

登入成功